CRIS Current Research Information System

VAIRA, BERARDINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.085
AS - Asia 12.593
NA - Nord America 11.491
SA - Sud America 1.086
AF - Africa 401
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 14
Totale 39.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.341
IT - Italia 7.948
SG - Singapore 4.010
VN - Vietnam 3.244
CN - Cina 2.838
GB - Regno Unito 1.559
HK - Hong Kong 1.038
DE - Germania 872
BR - Brasile 842
SE - Svezia 659
NL - Olanda 574
FR - Francia 531
IN - India 448
UA - Ucraina 439
RU - Federazione Russa 430
IE - Irlanda 244
JP - Giappone 186
KR - Corea 169
FI - Finlandia 164
ZA - Sudafrica 159
BG - Bulgaria 120
CH - Svizzera 113
EE - Estonia 112
AR - Argentina 97
JO - Giordania 96
ID - Indonesia 82
CA - Canada 72
ES - Italia 72
SC - Seychelles 65
TH - Thailandia 63
PH - Filippine 61
BD - Bangladesh 60
IQ - Iraq 54
CI - Costa d'Avorio 50
MX - Messico 49
AT - Austria 42
TR - Turchia 41
PL - Polonia 40
BE - Belgio 38
EC - Ecuador 38
PK - Pakistan 36
TW - Taiwan 32
TG - Togo 27
PY - Paraguay 26
AL - Albania 25
GR - Grecia 24
CO - Colombia 23
SA - Arabia Saudita 22
MY - Malesia 17
PE - Perù 17
VE - Venezuela 17
EU - Europa 16
RO - Romania 16
EG - Egitto 15
MA - Marocco 15
UZ - Uzbekistan 14
CL - Cile 13
DO - Repubblica Dominicana 13
KE - Kenya 13
LB - Libano 13
LT - Lituania 11
AU - Australia 10
TN - Tunisia 10
IR - Iran 9
LY - Libia 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
IL - Israele 8
DZ - Algeria 7
PS - Palestinian Territory 7
ET - Etiopia 6
HR - Croazia 6
NG - Nigeria 6
NP - Nepal 6
AZ - Azerbaigian 5
BO - Bolivia 5
KZ - Kazakistan 5
PT - Portogallo 5
DK - Danimarca 4
GA - Gabon 4
OM - Oman 4
RS - Serbia 4
SI - Slovenia 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
LU - Lussemburgo 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BH - Bahrain 2
CG - Congo 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
Totale 39.648
Salva come PNG Salva come JPEG
Città #
Singapore 2.430
Southend 1.352
San Jose 1.126
Hong Kong 998
Ashburn 987
Santa Clara 904
Fairfield 814
Ho Chi Minh City 799
Milan 791
Chandler 673
Hanoi 658
Rome 581
Boardman 545
Woodbridge 416
Hefei 404
Wilmington 400
Seattle 380
Bologna 377
Princeton 367
Houston 354
Beijing 352
Naples 307
Jacksonville 289
Cambridge 283
Ann Arbor 249
Dong Ket 246
Dublin 243
Lauterbourg 195
Padova 179
Turin 171
Tokyo 162
Nanjing 160
Los Angeles 158
Westminster 149
Seoul 141
Helsinki 138
Bari 137
New York 132
Sofia 119
Florence 118
Berlin 114
Buffalo 110
Da Nang 104
Amman 94
Haiphong 93
Palermo 92
Jinan 82
Verona 78
São Paulo 77
Guangzhou 74
Catania 72
Shanghai 70
Saint Petersburg 69
Shenyang 66
Brescia 60
Council Bluffs 60
Redondo Beach 60
Tappahannock 60
Frankfurt am Main 58
San Diego 58
Mülheim 57
Nanchang 55
Genoa 54
Chicago 53
Changsha 52
Modena 52
Parma 51
Abidjan 50
Frattamaggiore 50
Tianjin 47
Dallas 43
Reggio Emilia 42
Biên Hòa 41
Pescara 41
Redmond 41
Zhengzhou 41
Hải Dương 40
Des Moines 39
Hangzhou 39
Falkenstein 38
Hebei 36
Trieste 36
Can Tho 35
Yubileyny 35
Orem 34
Dearborn 33
Mahé 33
Thái Nguyên 33
Brussels 32
Nuremberg 32
Bengaluru 31
Bangkok 30
Rio de Janeiro 29
Boydton 28
Quận Bình Thạnh 28
Shenzhen 28
Cagliari 27
Lomé 27
Lucca 27
Medford 27
Totale 22.382
Salva come PNG Salva come JPEG
Nome #
Helicobacter pylori. Benedetto il giorno che ti ho incontrato 5.857
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale. 1.035
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 560
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 379
Attuali criteri di terapia dell’infezione da Helicobacter pylori. New treatment of Helicobacter pylori infection 280
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 266
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 230
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 223
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 222
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 220
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 205
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 205
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility 204
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 199
Effects of Helicobacter pylori eradication on early-stage gastric mucosa associated lymphoid tissue lymphoma. 198
H. pylori antibiotic resistance and 13C urea breath test values. 198
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 198
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 196
Cross-sectional study: CagA-positive helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide 194
13C-urea breath test values and Helicobacter pylori eradication 193
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance. 191
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 188
Gastroesophageal Reflux Disease and Barrett’s Esophagus 188
Response to Dr Osato and Graham 185
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 183
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 182
Test rapido per la determinazione della chemiosensibilità dell'Helicobacter pylori 179
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 177
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 176
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 175
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 174
Diagnosi dell’infezione da Helicobacter pylori 173
Diagnosi non invasiva e terapia per Helicobacter Pylori 172
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 169
A human domain antibody and Lewisb–glyconjugate that inhibit binding of Helicobacter pylori to Lewisb receptor and inhibit bacterial adhesion to human gastric epithelium 168
Phenotypic and genotype H. pylori Clarithromycin resistance and therapeutic outcomes: benefit and limits. 168
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 168
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 168
Nuove terapie per curare l’infezione da Helicobacter pylori 166
Therapy for H. pylori: Current concepts 166
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy? 165
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease 162
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 162
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 160
In vivo dissolution of levothyroxine soft gel capsules 160
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 160
Treatment of Helciobacter pylori infection 2014 158
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 158
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 156
Management of helicobacter pylori infection-the Maastricht V/Florence consensus report 156
Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori 156
Peptic ulcer and Helicobacter pylori. 155
Growth and adult height in atypical coeliac patients, with or without growth hormone deficiency. 153
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 153
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial 152
Diagnosis of Helicobacter pylori: invasive and non- invasive tests 152
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 151
An Atlas of Investigation and Management: HELICOBACTER PYLORI 151
The prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid nineties: an 18-yr longitudinal study based on anti-endomysial antibodies 151
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 149
Are Helicobacter Species and Enterotoxigenic Bacteroides fragilis Involved in Inflammatory Bowel Disease? 149
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 148
Helicobacter pylori: current status and future prospects 147
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 146
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 144
Diagnosi dell'infezione da Helicobacter pylori 144
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 143
Serological markers for gastric atrophy in asymptomatic subjects infected with Helicobacter pylori. 143
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 143
Global eradication rates for helicobacter pylori infection: systematic review and meta-analysis of sequantial therapy 143
The A2143G point mutation of Clarithromycin resistance affects H. pylori eradication 142
Probiotici ricombinanti e loro potenziale sulla salute umana 142
Helicobacter pylori and functional dyspepsia: an unsolved issue? 141
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis 141
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 140
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 139
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 139
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 137
Twice daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomised controlled trial using standard and double doses of omeprazole within a triple therapy 137
Recombinant probiotics and their potential in human health 137
Efficacy of 5-ASA in the treatment of colonic diverticular disease. 137
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children 137
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 136
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 136
Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H pylori 136
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 135
Treatment of Helicobacter Pylori in Latin America 134
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori 134
Considerable use of furazolidone in Iran. 132
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 132
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 132
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 131
Glaucoma and Helicobacter pylori: Eyes wide shut? 131
Letter: years of life that could be saved by preventing HCC 131
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 130
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 129
Sequential therapy for H pylori eradication: is Levofloxacin better? 128
Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic patients 128
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for Clarithromycin resistance in Helicobacter pylori. 127
Stool test for Helicobacter pylori 127
Totale 23.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021741 0 0 0 0 0 0 0 0 0 117 99 525
2021/20222.935 308 81 181 295 292 137 60 219 91 92 706 473
2022/20233.143 317 376 185 343 170 237 129 184 588 143 316 155
2023/20243.401 482 336 191 291 187 292 170 130 145 361 429 387
2024/20259.979 555 1.065 607 672 1.984 694 963 631 496 541 355 1.416
2025/202613.777 1.439 1.204 1.532 1.254 1.639 920 1.171 1.123 2.595 900 0 0
Totale 40.453